Bioengineered · 2019 · 36 citations · 15 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer ProgressionEpithelial-mesenchymal TransitionEsophageal CancerLung MetastasisMalignant NeoplasmsSquamous Cell CarcinomaEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersMetastatic Esophageal CancerMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna Regulation Of EmtTumor Metastasis Biology
MiR-25 is a well-documented oncogenic miRNA implicated in esophageal squamous cell carcinoma (ESCC) development, progression and metastasis. However, whether and how miR-25 is involved in the development and metastasis of ESCC remain un-addressed. By using qRT-PCR analysis to compare levels of miR-25 in ESCC tissues with or without lymph node metastasis (LNM), it showed that ESCC tissues with LNM had increased levels of miR-25, which was correlated with tumor metastasis and poor prognosis. Gain- and loss-of-function assays indicated that targeting miR-25 could reverse EMT, and reduce in vitro cell migration and invasion, but not apoptosis and proliferation of ESCC. Furthermore, targeting miR-25 inhibited in vivo lung metastasis, and vice versa. And E-cadherin was a direct target of miR-25 through which affected EMT process and metastasis of ESCC. It is therefore indicated that miR-25 promotes metastasis of ESCC through E-cadherin and EMT events, thus may serves as a negative prognostic factor and possible target for treatment of ESCC patients.
15
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
Susumu Eguchi, Mitsuhisa Takatsuki, Akihiko Soyama et al. · Hepatogastroenterology · 2011 · 1.8K citations · Full text
Diagnostic and Prognostic Implications of a Serum miRNA Panel in Oesophageal Squamous Cell Carcinoma
Caiyun Wu, Cheng Wang, Xiaocui Guan et al. · PLoS ONE · 2014 · 108 citations · Full text